OLYMPUSby New Odyssey
Menu
SEC registrant · CIK 0001567098

Luckwel Pharmaceuticals Inc.

Luckwel Pharmaceuticals Inc. (CIK 0001567098, EIN 46-1660653) reported net income of -$436,013 for FY2021 (2020-04-01 to 2021-03-31) and total assets of $46,681 for FY2021 (as of 2021-03-31), as filed in its 10-K filed 2021-09-09 (accession 0001493152-21-022312).

Figures are as filed with the SEC in XBRL, in whole US dollars unless stated, for the company's own fiscal years (fiscal year ends March 31).

Data as of Oct 21, 2026 (Olympus publication) · Markdown version

  • Values are as filed by the company in its 10-K and 10-Q XBRL data. When a later filing restates a value, the latest filed value is shown and the first reported value is noted.

Identifiers

As published in the company's EDGAR submissions record.

IdentifierValue
CIK0001567098
EIN46-1660653
SIC industry code2834 Pharmaceutical Preparations
State or country of incorporationNV
Fiscal year endMarch 31
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
Olympus entity IDorg_13jpt6v9ej549yqj8gd156h1cx
  • The EIN is the one the filer gave to EDGAR. The SEC does not verify it; Olympus checks only that it has nine digits and a prefix the IRS assigns.

Latest annual financial metrics

The latest annual value of each standardised metric, with the filing it was taken from.

MetricValueFiscal periodPeriodFormFiledAccession numberXBRL concept
Net income-$436,013FY20212020-04-01 to 2021-03-3110-K2021-09-090001493152-21-022312NetIncomeLoss
Total assets$46,681FY2021as of 2021-03-3110-K2021-09-090001493152-21-022312Assets
Total liabilities$490,949FY2021as of 2021-03-3110-K2021-09-090001493152-21-022312Liabilities
Stockholders' equity-$444,268FY2021as of 2021-03-3110-K2021-09-090001493152-21-022312StockholdersEquity
Operating cash flow-$197,975FY20212020-04-01 to 2021-03-3110-K2021-09-090001493152-21-022312NetCashProvidedByUsedInOperatingActivities
Diluted earnings per share-$0.003 per shareFY20212020-04-01 to 2021-03-3110-K2021-09-090001493152-21-022312EarningsPerShareBasicAndDiluted
Shares outstanding147,163,500 sharesFY2021as of 2021-08-3110-K2021-09-090001493152-21-022312EntityCommonStockSharesOutstanding
  • Accession numbers link to the filing's index on SEC EDGAR.

Revenue and net income history

Every annual revenue and net income value served for fiscal years 2012-2021, newest first, each with its filing.

MetricFiscal periodPeriodValueFormFiledAccession number
Net incomeFY20212020-04-01 to 2021-03-31-$436,01310-K2021-09-090001493152-21-022312
Net incomeFY20202019-04-01 to 2020-03-31-$536,43210-K2021-09-090001493152-21-022312
Net incomeFY20192018-04-01 to 2019-03-31-$622,52610-K2021-06-100001493152-21-014053
Net incomeFY20182017-04-01 to 2018-03-31-$537,08810-K2019-07-020001493152-19-010056
Net incomeFY20172016-04-01 to 2017-03-31-$510,70810-K2018-07-160001493152-18-009999
Net incomeFY20162015-03-01 to 2016-02-29-$420,72810-K2017-06-270001185185-17-001459
Net incomeFY20152014-03-01 to 2015-02-28-$264,15510-K2016-05-020001520138-16-000886

Recent 10-K and 10-Q filings

The 12 most recent 10-K, 10-Q and amendment filings in EDGAR, newest first.

FormFiledPeriod of reportAccession numberDocument
10-K2021-09-092021-03-310001493152-21-022312form10-k.htm
10-Q2021-09-082020-12-310001493152-21-022174form10-q.htm
10-Q2021-09-082020-09-300001493152-21-022134form10-q.htm
10-Q2021-09-072020-06-300001493152-21-022056form10-q.htm
10-K2021-06-102020-03-310001493152-21-014053form10-k.htm
10-Q2020-02-132019-12-310001493152-20-002208form10-q.htm
10-Q2019-11-142019-09-300001493152-19-017346form10-q.htm
10-Q2019-08-142019-06-300001493152-19-012580form10-q.htm
10-K2019-07-022019-03-310001493152-19-010056form10-k.htm
10-Q2019-02-142018-12-310001493152-19-002019form10-q.htm
10-Q2018-11-142018-09-300001493152-18-015946form10-q.htm
10-Q2018-08-142018-06-300001493152-18-011877form10-q.htm

Identifier registry

The company's identifiers in the Olympus identifier registry, each with how it was linked and its source.

SchemeValueHow linkedSourcePublished
SEC Central Index Key (CIK) · OLY-US-SEC-CIK0001567098published by the sourcedata.sec.gov/submissions/CIK0001567098.json2026-10-21
Employer Identification Number (EIN) · US-EIN46-1660653published by the sourcedata.sec.gov/submissions/CIK0001567098.json2026-10-21

Former names

NameFromTo
Luckycom Pharmaceuticals Inc.2017-04-192018-03-19
LUCKYCOM INC2013-04-122017-04-03

Sources

  • EDGAR submissions (nightly bulk archive) (company profile and filings) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:f7d2a4f18cb91aae, source date 2026-10-20. https://data.sec.gov/submissions/CIK0001567098.json
  • EDGAR XBRL company facts (nightly bulk archive) (financial metrics) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:01e4045aa34d7224, source date 2026-10-20. https://data.sec.gov/api/xbrl/companyfacts/CIK0001567098.json
  • Published by Olympus on Oct 21, 2026.
  • Source data: U.S. Securities and Exchange Commission (EDGAR). Values are as filed by the registrant; Olympus does not audit or adjust them.
  • Olympus is not affiliated with or endorsed by the U.S. Securities and Exchange Commission.

Get this data from the API

The same figures, with provenance on every value, from the API (free API key, reference) or from an AI agent through the Olympus MCP server.

curl
curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001567098" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001567098/financials" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001567098/filings?limit=12" -H "X-API-Key: $OLYMPUS_API_KEY"
MCP tool call
get_sec_company_financials {"cik":"1567098"}

On SEC EDGAR

About this data